Correction: Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
Oncotarget
.
2021 Nov 9;12(23):2321-2322.
doi: 10.18632/oncotarget.27474.
Authors
Manabu Seino
1
,
Tsuyoshi Ohta
1
,
Akiko Sugiyama
1
,
Hirotsugu Sakaki
1
,
Takeshi Sudo
1
,
Seiji Tsutsumi
1
,
Shogo Shigeta
2
,
Hideki Tokunaga
2
,
Masafumi Toyoshima
2
,
Nobuo Yaegashi
2
,
Satoru Nagase
1
Affiliations
1
Department of Obstetrics and Gynecology, Yamagata University School of Medicine, Iidanishi, Yamagata 990-9585, Japan.
2
Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
PMID:
34786186
PMCID:
PMC8590814
DOI:
10.18632/oncotarget.27474
Abstract
[This corrects the article DOI: 10.18632/oncotarget.25868.].
Copyright: © 2021 Seino et al.
Publication types
Published Erratum